chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 days after injection soreness developed in my left armpit and soreness in left and right side of neck - where lymph nodes are.  5 days after soreness in lymph nodes in neck were gone. Tender and soreness in armpit continued. 6 days after noticed for the first time redness and skin slightly raised at injection site. No itching or burning which is why I didn't notice until I saw my arm in the mirror. Soreness and tenderness still in armpit.    My conclusion is that my lymph nodes are swollen and tender. There is no additional pain or discomfort.  Treatment - Massaging lymph nodes with hopes to helping them drain.
About 8-10 hours after injection, I had chills, low grade fever and body aches and pain at injection site. These lasted through the night. round 10 the following morning, chills and fever slowly subsided and, aside from tiredness, I returned to my normal self by late afternoon. Pain at injection site lasted 3 days.
3 weeks post booster dose, I developed pancytopenia with neutropenic fever, continuous vomiting, fevers, fatigue, hepatosplenomegaly and ferritin as high as 19,570. Was diagnosed with Macrophage Activation Syndrome and underlying Systemic Lupus Erythematosus (never diagnosed until this event). Was hospitalized twice due to severe hemolytic anemia and neutropenia (0 neutrophils on blood smears), high D-dimer/clotting risk. Lost mobility temporarily due to fatigue, nutritional deficiencies, weakness, low blood oxygen due to anemia causing vasovagal events when walking or standing.
I thought I was having allergy symptoms but my wife tested positive for COVID-19 and I tested positive the next day. I tested positive on 09/23/2021 and I got an antibody infusion on 09/24/2021. I was very congested and I had a Sinus headache. I was mildly fatigued and I could not taste fully. My worst symptoms lasted about 4 days. I was also having some allergy symptoms. It has been two weeks and I am still easily fatigued and I have joint pain and weakness that started 10 days after the onset. My knees are the most painful as well as my finger joints.
Pt states had severe chills Friday evening and all day Saturday. Pt did not take temperature. Pt states are swelled up into neck and down to elbow twice the normal size. Had rash on arm, shoulder and under arm. Pt unable to move arm.
rash got better and about 12 days ago it got worse; weight has gone down substantially; This is difficult for him to talk about or hear about therefore very stressful; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient's wife). A 72-year-old male patient received BNT162B2 (Lot ZN6200, second dose) solution for injection intramuscular in left arm on 20Mar2021 (at the age of 72-years-old) as a single dose for COVID-19 immunization. There was no medical history. Concomitant medications were not reported. Historical vaccine included BNT162B2 (first dose, lot EL3248) for COVID-19 vaccination on 20Feb2021 and experienced bullous pemphigoid, severe rash blisters from his neck all the way down to his legs, arms, back and chest, anxiety, loss of weight, mental distress, itching a little bit, dry skin, stinging, and knee and foot got swollen. In Mar2021, the patient had a rash which got better and about 12 days ago it got worse which resulted in emergency room visit and physician office visit. In 2021, the patient weight has gone down substantially and this was difficult for him to talk about or hear about therefore very stressful. Treatment for the event rash included doxycycline. Lab tests in 2021 included cholesterol and triglycerides: low, it came back that he was healthy; blood tests: unknown; lot of tests: all came back negative; urine tests: unknown. The outcome of the event rash was not recovered. The outcome of the other events was unknown.  Follow-up (09Nov2021): Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101515942 same reporter/drug, different patient, similar AE
site redness; congestion; chest tightness; aching arms and legs; sore tongue; sore throat; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd September 2022, the patient received the 2nd dose of Shingrix. On 23rd September 2022, 1 days after receiving Shingrix, the patient experienced injection site erythema, nasal congestion, chest tightness, pain in extremity, sore tongue and sore throat. On an unknown date, the outcome of the injection site erythema, nasal congestion, chest tightness, pain in extremity, sore tongue and sore throat were not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema, nasal congestion, chest tightness, pain in extremity, sore tongue and sore throat to be related to Shingrix.     Additional Information: GSK Receipt Date: 23-Sep-2022 Reporter's comment: The patient self-reported this case. Next day of vaccination, the patient experienced sore throat, sore tongue, site red, aching arms and legs, chest tightness, congestion.  The reporter consented to follow up.
5/22/2021 I was very sick that evening after having my vaccination. I had to crawl to get something to drink. I was knocked out. I began having a very bad pain in my right lower leg. Then my leg went numb. It felt like my leg just drug. My asthma also got worse with breathing issues and I had a bad headache. I went two days like this. Ever since then, I get episodes like this. My leg gets numb, like a rubber band, I have to drag it along. These episodes would last for about 3 days. It may go as long as a month and then the symptoms would come back again. I will also got sleep paralysis after the vaccination. At my regular Neurologist appointment, he said it was inconclusive. No medications were prescribed and no tests were performed.
Information has been received from consumers concerning their current 5 year old female daughter with no pertinent medical history, drug reactions or allergies who "when 3 years old" in approximately 2007 was vaccinated with a first dose of MMR II (Lot# unknown). There was no concomitant medication. Consumers reported that was found out recently that "mumps was lacking". On an unspecified date blood test was performed and showed "mumps was lacking". The patient sought medical attention by an office visit. At the time of the report, the patient's outcome was unknown. Additional information has been received from physician concerning a 5 year old female patient with no pertinent medical history or no known drug allergies who on 05-JUN-2008 was vaccinated with the first dose of MMR II (Lot number 656528/0281U) subcutaneously. There was no concomitant medication. On 26-MAY-2010 the patient underwent a mumps immunoglobulin G antibody test which was <0.91 (negative). The physician stated that it was not an adverse event but that the patient did not get the required 2 doses of MMR II, per mother's request. Additional information is not expected.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 17-MAR-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J014235 and expiry date; 07-MAY-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Within a few hours of receiving the vaccine, I felt stomach pains, had chills, was extremely tired and lethargic.  I felt like I had the flu.  These symptoms continued for about 24 hours.   I am still very tired and do not feel entirely normal 36 hours after the vaccine but I am much better than I was.
Received FLUMIST on 11/13/09, developed Fever up to 104F x 4 days, associated with severe cough, mild hemoptysis, hoarse voice.
Patient received 1st dose of Moderna Covid-19 immunization at around 3:10pm on 3-4-21. Patient stood up fine after receiving it, but when he reached over to the counter to grab his keys and phone, he collapsed and hit the counter, breaking the counter off the wall on the way down. Patient remained conscious and sat up and leaned against the wall for around 20 minutes. He was sweaty but did not want us to call an ambulance. After around 20 minutes of resting, the patient looked much better, was no longer sweating, and was able to stand up just fine. He said he felt totally back to normal now, he absolutely did NOT want us to call an ambulance or a family member to help him. He said he was more than fine driving home. He looked much better and then left.
I had my vaccination on 10/14/2022. On 10/20/2022 I started to feel weak lightheaded and dizzy. I went to donate blood but was told hemoglobin was low. I had blood panel done and it shows iron is low. This could be diet related. This transpired after vaccination.
6 X 2 inch strip of rash just under both breasts around 12 pm.  Shower followed by application of aloe eliminated it within an hour.  Next day about 11 am, there was a light Rash at bottom of bicep area on right hands.  Again shower then aloe eliminated it within 2 hours.
Administered vaccine on 10/22/18. On 10/27, mom noted few red spots on site of injection site. Follow day 10/28, noted increased swelling, redness at site of injection. On 10/29 night and this morning, mom noted red bumps diffusely on upper/lower (R) extremities and buttocks.
23JUN98 got hives all over body;presently rash only on leg;parents giving 2tsp DPH q4hr PRN itching & rash;
Fever, body aches, stiffness, and diarrhea.  The body aches started a day before the fever and lasted the day after.  The diarrhea started the day of the fever and lasted part of the day after. Additionally headaches have been constant since the day of the vaccination. Additionally the first few days from receiving the vaccine were weakness and body ache that had gone away before the fever occurred.
mild URI symptoms; fever; confirmed COVID-19; confirmed COVID-19; This is a spontaneous report from a contactable consumer or other non-health care professional. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single and dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation and co-suspect moderna covid-19 vaccine (COVID-19 VACCINE MRNA (MRNA 1273)), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at dose 1, single for immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that "three patients, all since 01Jul2021, with PCR-confirmed COVID-19. Isolates sent for genotypic profiling - probably get results next winter. 2 with relatively mild URI symptoms but fever 100 (+). All received mRNA vaccine (Pfizer x 2, Moderna x 1) between Feb2021 and Apr2021. None with classic immunocompromising conditions but 1 was a robust 76". The events vaccination failure and Covid-19 were assessed as serious (medically significant). The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 01Jul2021 and pyrexia: 100 (+) fahrenheit on an unspecified date. Therapeutic measures were taken as a result of events include TLC (tender loving care) with every other day follow-up. The outcome of the events was unknown.  Information about batch/lot number has been requested.
This spontaneous report was received from a physician via a company representative concerning a female patient of an unknown age. The patient's medical history and concomitant drugs were not reported. The patient had an allergic reaction to BENADRYL. On an unknown date, the patient was vaccinated with PNEUMOVAX 23 intramuscular (dose, lot number and expiration date were not reported) for prevent pneumonia (prophylaxis). On an unknown date after receiving PNEUMOVAX 23, the patient experienced "swelling in the entire arm". It was reported that an unspecified treatment was given for the event. On an unknown date, the patient contacted with her physician. At the time of reporting, the outcome of the event was recovered on an unknown date. The causal relationship between the event and PNEUMOVAX 23 was not reported. Additional information has been requested.
Pt recv vax on 12/16/98;  4hr post vax pt exp edema in stomach, hands, wrists, generalized hives; tx=Benadryl; pt imp 24 hr
Patient in observation and complains of throat swelling/tingling, and difficulty swallowing. Vital signs, BP-125/90, HR-90. Benadryl 50mg given orally.  Patient monitored. Vital signs BP-131/91, HR-92, RR-15.  Patient verbalizes feeling better. Patient AOx4, GCS 15, no signs of injury, redness or hives noted. Patients lungs sounds clear bilaterally.  Patient educated about adverse reactions. Patient advised when to call 911 or seek medical attention. Patient verbalizes understanding.
Upper left thigh with 8 x 8 cm area red, warm, swollen, non tender. No other reaction. Reassurance, cool compresses.
Shortness of breath / Can't catch my breath; decreased stamina after mild exertion; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program. A 39-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection) via an unknown route of administration administered in arm left on an unknown date in Mar2021 at 08:00 am as single dose for covid-19 immunization. The patient had no allergy. The patient's medical history and concomitant medication were not reported. The patient received most recent COVID-19 vaccine was administered at Health Clinic. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. On 27Mar2021, patient experienced shortness of breath and decreased stamina after mild exertion, could not catch his breath. Patient did not receive any treatment for the adverse events. The outcome of events was recovered/resolved with sequel.  Information about lot/batch number cannot be obtained. No follow-up attempts are needed. No further information is expected.
Fever to 103 degrees night of vaccines (6-14-18), rash all over the body next day. Fever and rash x 3 days resolved together on it's own.
Large reddened area noted to right arm around site of injection.  Mother reported to office that the area was inflamed and warm to touch.  Mother states area was as large as "the palm of my hand".
Narrative:  55yo male died on 03/16/2022 at home. Pt died of stage 4 brain cancer. Pt had received a covid vaccine eua, (J&J) on 3/16/2021. This death is not related to the covid vaccine.
8/12/02 seen for puncture wound R index finger with retained metal FB. Td given Rx Keflex 500mg po qid #20. Pt referred to hand specialist for FB removal performed 8/13/02 with nerve block. At 8/20/02 FU appt pt c/o side effect to Td which became very stiff, sore, unable to move arm through weekend and stayed home from work 8/19/02. Sx (-) N/T. Finger resolved. Td injection site (-) erythema/edema. Still resolving 8/23/02.
Initial and follow-up information has been received from a health professional through the Merck pregnancy registry concerning a 23 year old female smoker with no drug allergies, who on 30-JAN-2007 was vaccinated intramuscularly with a 0.5mL first dose of GARDASIL.  On 30-MAR-2007 the patient was vaccinated with a second dose of GARDASIL.  On 31-JUL-2007 the patient was vaccinated with a third dose of GARDASIL (Lot# 658222/0927U).  There was no concomitant medication.  Subsequently, the patient was pregnant and reported to be in her first trimester.  The patient took a home pregnancy test that was positive.  On 10-SEP-2007 prenatal blood work was taken and an ultrasound was performed that was normal.  The patient's last menstrual period was 03-JUL-2007 and her estimated delivery date was 09-APR-2007 (also reported as 11-APR-2008).  The patient called the office.  The patient had one previous pregnancy that resulted in a spontaneous abortion.  At the time of the report, the patient's outcome was unknown.  No product quality complaint was involved.  On 02-MAR-2008 the patient went into pre-term labor at 34 weeks with abruptio placenta and delivered a male baby that weighed 2175 grams.  It was reported that the baby was in the hospital NICU on oxygen and was receiving unspecified antibiotics.  The mother was bottle-feeding the baby.  The length of stay in the NICU, and the reason for the infant being treated with oxygen and unspecified antibiotics was not reported.  No further information was available on the baby's condition.  This is an amended report.  The serious criteria for hospitalization has been changed to yes for premature baby and birthweight low.  Additional information has been requested.
Information has been received from a pharmacist referring to a newborns (numbered 23). Since June 2015, there had been 1645 times (30 minutes each time=822.5 hours) that the temperature dropped below 36F. Of course, there was 144 times (30 minutes each time=72 hours) that temperature was below 32F, the lowest being 29.7F. On 04-JUL-2015, there was a low temperature of 30.2F. On 12-JUL-2015 the patients were vaccinated with the improperly stored RECOMBIVAX HB strength 2.5/0.5 (units not provided) (lot number K020216 and expiration date of 17-SEP-2016) (dose and route of administration were not reported). There was no product quality complaint (PQC). This is one of several reports received from the same reporter. Additional information has been requested.
at 25 days after shot she developed the worst headache of her life 10/10, swollen glands in her neck, malase, significant hypersensitivity to touch, myalgia and myositis. She was hospitalized for 4 days with negative work up for any infection, menningitis or known viral illness. She was on multiple narcotic and non narcotic pain medications that did not help her pain.  9/17/09 Received hospital medical records for 9/9-9/12/20009. FINAL DX: headache, neck stiffness,  & abdominal pain Records reveal patient experienced HA & neck stiffness x 6 days w/photophobia/phonophobia & abdominal pain x 1 day.  Tx w/IVF, pain & nausea meds, IV antibiotics, & oral steroids.  ENT consult done & dx w/cervical lymphadenitis secondary to viral syndrome & muscle spasms.  D/C to home w/PCP f/u, on pain meds & steroid taper.
Pharmacist states they gave full doses for boosters instead of half doses.; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milligram. On 25-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.). On 25-Oct-2021, ACCIDENTAL OVERDOSE (Pharmacist states they gave full doses for boosters instead of half doses.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided  Caller stated that patients first dose was a JNJ dose.
Disorientated, sweating more than ever in my life, explosive diarrhea, weakness, little movement in my arm I received the shot in. Pain under my left breast would come and go till day after the shot. Today 02/05/2016 a lot of pressure in my head, sleepy, no appetite and weak, pain in rt. heel and ankle muscle.
Rash/hives covering complete body.  Treating with methylPREDNISolone (six days)
The patient reports  she has a tickle on her throat before covid Moderna vaccine  Patient had Moderna vaccine administered 01/04/2021  at approximately 8:30AM and begin experiencing  shortness of breath, wheezing, fatigue and chills at approximately 7pm that evening. on 01/05/2021 she developed a  wet cough since then Symptoms have not improve and reports  on 1/21/2021  she has severe wheezing shortness of breath wet cough.
Redness, mild swelling, warmth at the injection site. Treatment: Ice pack to the area and Benadryl at night as needed for itching
Cellulitis (severe), Emergency room and Dr visit elevated WBC. Levaquin, Elicon.
pt noticed swelling in throat & went to ER;there was given IV DPH & cortisone observed for several hours & discharged to home;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Oct2021 as dose 3 (booster), single (Lot number: FE3590) at the age of 72 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "thyroidectomy" (unspecified if ongoing); "Statin for cholesterol Control" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; SIMVASTATIN taken for blood cholesterol abnormal. The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (14May2022) Positive, notes: I took a home test 6 days after my last dose, and I tested positive again. Therapeutic measures were taken as a result of covid-19.  No follow-up attempts are possible. No further information is expected.